SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021208
Filing Date
2023-05-11
Accepted
2023-05-11 16:05:29
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stsa-20230331.htm   iXBRL 10-Q 2201805
2 EX-10.2 stsa-ex10_2.htm EX-10.2 137300
3 EX-31.1 stsa-ex31_1.htm EX-31.1 20947
4 EX-31.2 stsa-ex31_2.htm EX-31.2 20794
5 EX-32.1 stsa-ex32_1.htm EX-32.1 12085
6 EX-32.2 stsa-ex32_2.htm EX-32.2 12083
7 GRAPHIC img78965974_0.jpg GRAPHIC 59575
  Complete submission text file 0000950170-23-021208.txt   7411981

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stsa-20230331.xsd EX-101.SCH 40261
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stsa-20230331_lab.xml EX-101.LAB 347103
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stsa-20230331_pre.xml EX-101.PRE 240362
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stsa-20230331_def.xml EX-101.DEF 110840
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stsa-20230331_cal.xml EX-101.CAL 38524
51 EXTRACTED XBRL INSTANCE DOCUMENT stsa-20230331_htm.xml XML 1283979
Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39041 | Film No.: 23910891
SIC: 2834 Pharmaceutical Preparations